Your Mammogram Can Now Predict Cancer Before You Have It -- Here's the Doctor Making It Happen

The Cancer That Has No Symptoms — Until It's Too Late

Skin cancer is the most common cancer in the world — and the most survivable, if you catch it early. Dr. Ron Shore has spent 34 years and 28,000 patient screenings proving it. In this episode, he breaks down the three types of skin cancer, why melanoma can be silent until it's deadly, and the simple screening habits that could save your life. If you've ever skipped your annual skin check, listen to this first. Dr. Shore also shares his five essential tips for protecting yourself: get a thorough annual exam from a knowledgeable dermatologist, return for check-ups every six to twelve months, wear SPF 50 or higher whenever you're in the sun, encourage older loved ones with visible sun damage to get screened, and if you spot something new or unusual — don't wait, see a doctor now.

He Spent 3 Weeks Unplugged at the Bottom of the Grand Canyon — While Accidentally Revolutionizing Cancer Treatment

What happens when a curious biochemist follows his wife to California, falls in love with whitewater rafting — and accidentally makes one of the most important cancer discoveries of the 20th century? In this episode, we sit down with Dr. Tony Hunter, the 2025 St. Gyorgi Prize winner and Salk Institute legend, whose 1979 discovery of tyrosine phosphorylation laid the foundation for over 80 cancer drugs in use today. We talk about the moment the scientific world accepted his discovery, why America's cancer research dominance is now under serious threat, the "valley of death" killing promising treatments before they reach patients, and what AI can — and can't — do for the future of cancer medicine. Equal parts science, adventure, and a warning the research world needs to hear.

Your Mammogram Can Now Predict Cancer Before You Have It -- Here's the Doctor Making It Happen

What if you could know your breast cancer risk at 25 and actually do something about it? Dr. Funmi Olopade, a trailblazing oncologist at the University of Chicago, has spent 30 years rewriting the rules of breast cancer care, and she believes we can eradicate it as a cause of premature death within a decade. In this episode, she breaks down how AI, genetic testing, and a simple blood test are transforming early detection, why too many women are still being failed by a broken system, and what every woman should be doing right now, no matter their age. This is a conversation that could change how you think about your own health.

Doctors Gave Her 3 Years to Live. She Changed Cancer Research Instead.

At age 37, Kathy Giusti was diagnosed with multiple myeloma and told she had just three years to live. Instead of accepting that fate, she turned urgency into action and founded the Multiple Myeloma Research Foundation (MMRF), transforming how cancer nonprofits accelerate drug development. Today, more than 15 therapies have been approved for multiple myeloma and survival rates have more than doubled. In this episode of All Things Cancer, Dr. Sujuan Ba speaks with Kathy Giusti about her new book Fatal to Fearless, the leadership and strategy required to drive progress in cancer research, and how collaboration between nonprofits, academia, industry, and regulators can speed lifesaving treatments to patients. They also explore the future of cancer research, including venture philanthropy, data sharing, AI-driven discovery, and why patients must be empowered to advocate for themselves in a complex medical system.

Why Was Half This Village Dying of Cancer— And No One Stopped It?

Half a village was dying of cancer. No one could explain why. For the Season One finale of All Things Cancer, we’re ending with a story that changed the trajectory of cancer research — and saved generations of lives. What began as a keynote trip to Turkey turned into one of the most extraordinary cancer investigations in modern medicine. In this episode, Dr. Michele Carbone shares how he uncovered a deadly inherited mutation, confronted government officials, helped relocate entire villages, and identified the BAP1 gene — a discovery that transformed our understanding of mesothelioma and inherited cancer risk. But the twists don’t stop there. After four years, $10 million in funding, and zero published results, his research was on the brink of collapse. Then a 1-in-100-billion clue changed everything. In this episode, you’ll hear: * How a remote village in Turkey led to a global cancer breakthrough * The gene that can guarantee cancer — yet may also help patients survive it * The policy battle that protected future generations * Why Dr. Carbone warns against overreliance on AI in medicine * And how cooking helped him build a cancer center from the ground up This is a story about persistence, courage, and the power of research to move beyond the lab and into real lives. As we close out Season One, this conversation is a powerful reminder of why cancer research matters — and what’s possible when science meets compassion.